NCT05942911Phase 2Terminated

Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis

Study sponsor: Incannex Healthcare Ltd

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2024-10-28Actual
Enrollment · participants20Actual
Source updated2026-03-27Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Suspended. After: Terminated.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview